| Patients’ perspective of medication adherence in chronic conditions: a qualitative study N Pages-Puigdemont, MA Mangues, M Masip, G Gabriele, ... Advances in therapy 33, 1740-1754, 2016 | 151 | 2016 |
| Prevalence and clinical impact of recreational drug consumption in people living with HIV on treatment: a cross-sectional study N Garin, B Zurita, C Velasco, A Feliu, M Gutierrez, M Masip, MA Mangues BMJ open 7 (1), e014105, 2017 | 52 | 2017 |
| Determinants of medication adherence among chronic patients from an urban area: a cross-sectional study N Pages-Puigdemont, L Tuneu, M Masip, P Valls, T Puig, MA Mangues European Journal of Public Health 29 (3), 419-424, 2019 | 25 | 2019 |
| Prevalence and detection of neuropsychiatric adverse effects during hepatitis C treatment M Masip, L Tuneu, N Pagès, X Torras, A Gallego, JM Guardiola, MJ Faus, ... International journal of clinical pharmacy 37, 1143-1151, 2015 | 16 | 2015 |
| Results of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in clinical practice: a 5-year experience M Vergara, M Gallach, B Dalmau, M Gil, M Miquel, N Rudi, A Gavarro, ... Gastroenterologia y Hepatologia 31 (5), 274-279, 2008 | 13 | 2008 |
| Intervención del farmacéutico en la conciliación peroperatoria de la medicación crónica de pacientes quirúrgicos N Allué, B Bara, MJ Cabanyes, T Casasin, PD Sampedro, G Garau, ... El Farmacéutico. Hospitales, 19-32, 2008 | 8 | 2008 |
| Intervenció del farmacèutic en la millora del maneig perioperatori de la medicació habitual dels pacients quirúrgics C Roure, D López, T Casasín, EM Martínez, M Masip, P Domínguez, ... Barcelona: Col· legi de Farmacèutics de Barcelona, 2007 | 8 | 2007 |
| A cohort study of guselkumab in the treatment of psoriasis refractory to previous biologic therapies: effectiveness, safety and adherence D Medina-Catalán, P Riera, N Pagès-Puigdemont, M Masip, ... International Journal of Clinical Pharmacy 44 (3), 725-730, 2022 | 7 | 2022 |
| AB0402 THERAPEUTIC ADHERENCE AND PERSISTENCE OF TOFACITINIB AND BARICITINIB IN RHEUMATOID ARTHRITIS PATIENTS IN DAILY CLINICAL PRACTICE. H Codes-Mendez, C Martinez-Molina, M Masip, P Riera, NP Puigdemont, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 1330-1330, 2022 | 3 | 2022 |
| Resultados del tratamiento con interferón pegilado y ribavirina para la hepatitis crónica por el virus C en la práctica clínica. Experiencia de 5 años M Vergara, M Gallach, B Dalmau, M Gil, M Miquel, N Rudi, A Gavarro, ... Gastroenterología y Hepatología 31 (5), 274-279, 2008 | 3 | 2008 |
| Developing a mHealth intervention to redesign the current journey for people living with HIV: A qualitative study. A De Dios, M Masip, P Riera, MDM Gutiérrez, MA Mangues, ... Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad …, 2022 | 2 | 2022 |
| Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy E Colominas-González, M De Antonio, M Masip, MTM Conde, G Cardona, ... European Journal of Hospital Pharmacy, 2024 | 1 | 2024 |
| Treatment with Sofosbuvir+ Simeprevir for 12 Weeks in HCV Compensated Cirrhosis (Genotypes 1 and 4); The Use of Ribavirin Does Not Influence Sustained Viral Response A Gallego, E Alvarado, C Gely, N Pagès, M Masip, N Margall, X Torras, ... Journal of Hepatology 2 (64), S741-S742, 2016 | 1 | 2016 |
| 4CPS-076 Effectiveness and safety of dupilumab and tralokinumab in atopic dermatitis in clinical practice A Domínguez, M Masip, H Ruppmann, P Lozano, C Socias, A Plaza, ... European Journal of Hospital Pharmacy 31 (Suppl 1), A88-A88, 2024 | | 2024 |
| 4CPS-091 Real-life persistence, effectiveness and safety of fremanezumab in patients with chronic migraine S Ojeda, P Riera, N Pagès, M Masip, R Pelegrin, A De Dios European Journal of Hospital Pharmacy 31 (Suppl 1), A95-A96, 2024 | | 2024 |
| 5PSQ-113 Real-life effectiveness, safety and adherence of dupilumab in patients with atopic dermatitis CS Cañellas, P Riera, M Masip, E Serra-Baldrich, J Spertino, ... European Journal of Hospital Pharmacy 30 (Suppl 1), A149-A150, 2023 | | 2023 |
| Desarrollo de una intervención mHealth para rediseñar la ruta asistencial de las personas que viven con VIH: Estudio cualitativo A De Dios, M Masip, N Pagès-Puigdemont, P Riera, MG Mateo, ... FARMACIA HOSPITALARIA 46 (07), 47-58, 2022 | | 2022 |
| 4CPS-215 Persistence and therapeutic adherence to first-generation Janus kinase inhibitors in rheumatoid arthritis patients C Martinez-Molina, N Pages, P Riera, A Riera, H Codes, C Diaz-Torne, ... European Journal of Hospital Pharmacy 29 (Suppl 1), A193-A193, 2022 | | 2022 |
| Management of lipid-lowering therapy in PCSK9 inhibitors-treated patients A Aretio, Y Campos-Baeta, A Feliu, M Masip, MA Mangues INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 40 (1), 247-248, 2018 | | 2018 |
| Detection and management of potential herb-drug interactions during HCV treatment V Aguilera, N Pages, M Masip, X Torras, A Gallego, M Antonia Mangues INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 39 (1), 231-231, 2017 | | 2017 |
Neus Pagès-PuigdemontPharmD, PhD. Clinical Pharmacist. Hospital de la Santa Creu i Sant Pau (Barcelona)在 santpau.cat 的电子邮件经过验证
